Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) shares traded up 0.5% during trading on Tuesday . The company traded as high as C$2.26 and last traded at C$2.26. 1,200 shares were traded during trading, a decline of 64% from the average session volume of 3,297 shares. The stock had previously closed at C$2.25.
Genscript Biotech Stock Performance
The stock has a 50-day moving average price of C$2.21 and a 200-day moving average price of C$1.86.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- How Investors Can Find the Best Cheap Dividend Stocks
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- How to Invest in Blue Chip Stocks
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- How to Read Stock Charts for Beginners
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
